We are live on ! Find out more
XBIT icon

XBiotech
XBIT

32 hedge funds and large institutions have $12.1M invested in XBiotech in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

16% less funds holding

Funds holding: 38 → 32 (-6)

18% less capital invested

Capital invested by funds: $14.7M → $12.1M (-$2.61M)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
14
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$296K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$269K
3
State Street
State Street
Massachusetts
+$118K
4
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale
Germany
+$116K
5
Deutsche Bank
Deutsche Bank
Germany
+$38K

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$452K
2
NFA
Nationwide Fund Advisors
Ohio
-$296K
3
Millennium Management
Millennium Management
New York
-$171K
4
Goldman Sachs
Goldman Sachs
New York
-$151K
5
VKH
Virtu KCG Holdings
New York
-$113K
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
26
STRS Ohio
Ohio
$12K – – –
BA
27
BlackRock Advisors
Delaware
$10K – – –
Barclays
28
Barclays
United Kingdom
$3K -$2.97K -359 -53%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$2K -$389 -47 -19%
Wells Fargo
30
Wells Fargo
California
$2K +$2.12K +256 +985%
BlackRock
31
BlackRock
New York
$1K +$944 +114 New
Geode Capital Management
32
Geode Capital Management
Massachusetts
$389 +$5.29K +639 +2%
OAM
33
Oxford Asset Management
United Kingdom
– -$452K -42,282 Closed
Millennium Management
34
Millennium Management
New York
– -$171K -15,771 Closed
Goldman Sachs
35
Goldman Sachs
New York
– -$151K -13,848 Closed
VKH
36
Virtu KCG Holdings
New York
– -$113K -10,410 Closed
Bank of America
37
Bank of America
North Carolina
– -$57K -5,264 Closed
UBS Group
38
UBS Group
Switzerland
– -$25K -2,291 Closed
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
– -$14.7K -1,348 Closed
LTFS
40
Ladenburg Thalmann Financial Services
Florida
– -$7K -600 Closed
MA
41
MUFG Americas
New York
– -$6K -520 Closed
1
2

XBIT Hedge Fund Activity: Q1 2016 in Review

32 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2016, worth a combined $12.1M — down 18% from $14.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of XBIT and 3 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 14 added.

The largest buyer was BlackRock Fund Advisors, adding an estimated $296K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $452K sold.

  • 32 institutional investors held XBiotech (XBIT) as of Q1 2016, down from 38 in Q4 2015.
  • Funds reported $12.1M of XBiotech stock for Q1 2016, down 18% quarter-over-quarter.
  • 3 funds opened new XBiotech positions in Q1 2016 and 9 closed out, a net change of -6 holders.
  • The largest XBiotech buyer in Q1 2016 was BlackRock Fund Advisors, an estimated $296K added.
  • The largest XBiotech seller in Q1 2016 was Oxford Asset Management, an estimated $452K sold.

Based on aggregated 13F filings for Q1 2016.